Immunoreactivity, stability, pharmacokinetics and biodistribution of a monoclonal antibody to human leukemic B cells after three different methods of radioiodination
- 31 August 1994
- journal article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 21 (6), 873-882
- https://doi.org/10.1016/0969-8051(94)90167-8
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- N-Succinimidyl 4-methyl-3-(tri-n-butylstannyl)benzoate: Synthesis and potential utility for the radioiodination of monoclonal antibodiesNuclear Medicine and Biology, 1993
- Radioiodination of proteins using N-succinimidyl 4-hydroxy-3-iodobenzoateBioconjugate Chemistry, 1993
- Radioiodination of antibodies via N-succinimidyl 2,4-dimethoxy-3-(trialkylstannyl)benzoatesBioconjugate Chemistry, 1990
- Radioantibodies for the Diagnosis and Treatment of Cancer; Radioimmunoimaging (RAI) and Radioimmunotherapy (RAT)Cancer Investigation, 1990
- Limitations associated with the use of labelled antibodies against CEA for potential tumour localisation and therapy. A reviewEuropean Journal of Cancer and Clinical Oncology, 1986
- Radioimmunodetection of Cutaneous T-Cell Lymphoma with111In-Labeled T101 Monoclonal AntibodyNew England Journal of Medicine, 1986
- Radioiodination techniques for small organic moleculesChemical Reviews, 1982
- Cure of a mouse lymphoma with radio-iodinated antibodyEuropean Journal of Cancer (1965), 1974
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970
- Application of Stepwise Regression to Non-Linear EstimationTechnometrics, 1968